• Actoverco is an integrated pharmaceutical company with 103 products & over 1,000 employees operating in fields of importation, marketing, production and distribution.

    Investment in high standard production facilities and qualified personnel has positioned Actoverco as a partner for under license production in Iran. 


    FOCUS ON BIOSIMILARS

    Biosimilars represent some of the fastest-growing pharmaceutical products in the world. Actoverco's long term strategy includes strengthening partnerships and investing in this field. 

    We are committed to build a leadership position in Iran as well as region. Our biotech plant located in Baharestan industrial zone near Tehran started production in 2013 with a capacity of 10 million vials and PFS.


    OUR PARTNERS

    Whether it is for innovative products, branded generics or biosimilars, we select carefully the partners and the products entering Actoverco basket.

    We are the official distributor of 11 world-class pharmaceutical manufacturers. For over 40 years, they have trusted Actoverco with their products in the ever-changing Iranian market.

    Our commitment to our partners and our flexibility is the reason we have kept some of these partnerships throughout mergers, acquisitions, wars and revolution.

    We adjust our services to each company depending on their policies. From under license production with Merck, to cobranding with Krka or technology transfer in the case of biotech.

    Other most recent partners have chosen us because of our production capabilities to comply with MOH policies


    PRODUCTION SITES

    Actoverco is committed to adhere to the regulatory requirements and the highest industry standards.

    Our production facilities run by international standards. We have obtained ISO 9001, 14001, OHSAS 18001 and GMP (Good Manufacturing Practices) certifications, as well as the approval for under license manufacturing of Merck and Krka’s products in Iran.

    Actoverco ensures quality by a continuous monitoring of the quality systems, and the application of evolving industry guidelines and regulations.

    Quality is the responsibility of every Actoverco team member. 

    Actoverco solid form plant

    Started production in 2011

    Capacity: 1500 Million tablets and capsules

    Therapeutic areas of production: Cardiovascular, CNS, Gastrointestinal, Endocrinology, OTC


    Actoverco biotech plant

    Started production in 2014

    Capacity: 10 Million vials and pre-filled syringes

    Therapeutic areas of production: MS, Oncology

    Technology transfer from Amega Biotech and Mabxience


    Hormone Plant

    Atipharmed a separate hormone plant aims to cover production of contraceptives, hormone replacement therapy and endometrial drugs.

    Capacity: 700 million tablets

    First hormonal plant with GMP approval in the country

    Will include production lines for pessaries and cream as well as the existing SDF lines.


    General hazardous plant

    Alborz-Zagros is dedicated to the production of general hazardous drugs.

    Capacity: 800 million tablets

    First general hazardous plant in the country.


    Good Manufacturing Practice

    GMP is a regulatory guideline imposed on all manufacturers of pharmaceuticals to ensure that finished products have the identity, strength, quality and purity they are required to have. GMP describes the methods, the controls, the equipment and facilities that must be put into place for the manufacturing of pharmaceutical products.

    Actoverco ongoing auditing program verifies continuous adherence to GMP standards.


    MISSION STATEMENT

    Mission:

    We supply economic pharmaceutical products covering the needs of the market. By economic drugs, we mean high quality affordable branded pharmaceutical products.


    Vision:

    We aim to consolidate our position as one of the leading  pharmaceutical companies in the country. We are achieving this by strengthening the long-term business partnerships in the fields of development, product supply and marketing.


    Values:

    Our values shape the Actoverco way of doing business at every level of the company.

    • Quality oriented: We are committed to quality not only for our products but also in all our business processes.
    • Collaborative: We understand collaboration as the key to success.
    • Integrity: We see integrity and responsibility as a core characteristic for each member of our team.
    • Fast-moving: We are a fast moving company a quality needed in dynamic markets.

    Strategy:
    • Attain 25% annual growth
    • Strengthen pharmaceutical activities in the key therapeutic fields 
    • Enter new therapeutic fields
    • Respond to internal market demand and design a new marketing region
    • Increase investment in production 

  • LATEST PRODUCTS

    ROSUREXIN

    ROSUREXIN
    Generic name: Rosuvastatin
    Manufactured by: Actoverco
    Dosage: 5, 10, 20, 40 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    CONCOR

    CONCOR
    Generic name: Bisoprolol Fumarate
    Manufactured by: Merck
    Dosage: F.C. Tab
    Package: 30 tablets
    Prescribing information
    Report adverse events

    ADANCOR

    ADANCOR
    Generic name: Nicorandil
    Manufactured by: Merck
    Dosage: 10 , 20 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    OMACOR

    OMACOR
    Generic name: Omacor
    Manufactured by: Ferrer
    Dosage: 1000 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    BION3

    BION3
    Generic name: Bion3
    Manufactured by: Merck
    Dosage: F.C. Tab
    Package: 90 tablets
    Prescribing information
    Report adverse events

    BION3

    BION3
    Generic name: Bion3
    Manufactured by: Merck
    Dosage: F.C. Tab
    Package: 30 tablets
    Prescribing information
    Report adverse events

    FEMIBION2

    FEMIBION2
    Generic name: Femibion2
    Manufactured by: Merck
    Dosage: F.C. Tab
    Package: 60,120 tablets & Capsules
    Prescribing information
    Report adverse events

    FEMIBION1

    FEMIBION1
    Generic name: Femibion1
    Manufactured by: Merck
    Dosage: F.C Tab
    Package: 30, 60 tablet
    Prescribing information
    Report adverse events

    NEUROBION

    NEUROBION
    Generic name: Vitamin B1, B6, B12
    Manufactured by: Merck
    Dosage: 3 mg
    Package: 3 ampules
    Prescribing information
    Report adverse events

    EUTHYROX

    EUTHYROX
    Generic name: Levothyroxine sodium
    Manufactured by: Merck serono
    Dosage: 50, 100 micro g
    Package: 100 tablets
    Prescribing information
    Report adverse events

    GLUCOPHAGE

    GLUCOPHAGE
    Generic name: Metformin hydrochloride
    Manufactured by: Merck serono
    Dosage: 500, 1000 mg
    Package: 100 tablets
    Prescribing information
    Report adverse events

    TAMSOVER

    TAMSOVER
    Generic name: Tamsulosin
    Manufactured by: Actoverco
    Dosage: 0.4 mg
    Package: 30 capsules
    Prescribing information
    Report adverse events

    VIZARSIN

    VIZARSIN
    Generic name: Sildenafil
    Manufactured by: Krka
    Dosage: 50, 100 mg
    Package: 4 tablets
    Prescribing information
    Report adverse events

    TIZANOVER

    TIZANOVER
    Generic name: Tizanidine
    Manufactured by: Actoverco
    Dosage: 4 mg
    Package: 60 scored tablet
    Prescribing information
    Report adverse events

    ZOLIVER

    ZOLIVER
    Generic name: Zolpidem
    Manufactured by: Actoverco
    Dosage: 5, 10 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    NEURONTIN

    NEURONTIN
    Generic name: Gabapentine
    Manufactured by: Pfizer
    Dosage: 100, 300, 400 mg
    Package: 90 capsules
    Prescribing information
    Report adverse events

    QUENTIAX

    QUENTIAX
    Generic name: Quetiapine
    Manufactured by: Actoverco under license Krka
    Dosage: 25, 100, 200 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    YASNAL

    YASNAL
    Generic name: Donepezil
    Manufactured by: Actoverco under license Krka
    Dosage: 5, 10 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    ASENTRA

    ASENTRA
    Generic name: Sertraline
    Manufactured by: Actoverco under license Krka
    Dosage: 50, 100 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    ALVENTA

    ALVENTA
    Generic name: Venlafaxine
    Manufactured by: Actoverco under license Krka
    Dosage: 37.5, 75 mg
    Package: 28 capsules
    Prescribing information
    Report adverse events

    ACTOCOLD

    ACTOCOLD
    Generic name: Cold & flu
    Manufactured by: Actoverco
    Dosage: 4 in 1 preparation
    Package: 30 tablets
    Prescribing information
    Report adverse events

    XENOVER

    XENOVER
    Generic name: Orlistat
    Manufactured by: Actoverco
    Dosage: 120 mg
    Package: 21 capsules
    Prescribing information
    Report adverse events

    ACTOPIN

    ACTOPIN
    Generic name: Ibuprofen
    Manufactured by: Actoverco
    Dosage: 200, 400 mg
    Package: 20 tablets
    Prescribing information
    Report adverse events

    ACTOFEN EXTRA

    ACTOFEN EXTRA
    Generic name: Acetaminophen- caffeine
    Manufactured by: Actoverco
    Dosage: 500 mg Acetaminophen+ 65 mg Caffeine
    Package: 50 tablets
    Prescribing information
    Report adverse events

    ONKOTAXEL ACTAVIS

    ONKOTAXEL ACTAVIS
    Generic name: Docetaxel
    Manufactured by: Actavis
    Dosage: 20, 80 mg
    Package: vial
    Prescribing information
    Report adverse events

    ERIOPHOS

    ERIOPHOS
    Generic name: Zoledronic acid
    Manufactured by: Eriochem
    Dosage: 4mg /5ml
    Package: Concentrate solution
    Prescribing information
    Report adverse events

    VINORELBINE ACTAVIS

    VINORELBINE ACTAVIS
    Generic name: Vinorelbine
    Manufactured by: Actavis
    Dosage: 10, 50 mg
    Package: vial
    Prescribing information
    Report adverse events

    CARBOPLATIN ACTAVIS

    CARBOPLATIN ACTAVIS
    Generic name: Carboplatin
    Manufactured by: Actavis
    Dosage: 50, 150 mg
    Package: vial
    Prescribing information
    Report adverse events

    PACLITAXEL ACTAVIS

    PACLITAXEL ACTAVIS
    Generic name: Paclitaxel
    Manufactured by: Actavis
    Dosage: 30, 150 mg
    Package: vial
    Prescribing information
    Report adverse events

    FLUDARABINE ACTAVIS

    FLUDARABINE ACTAVIS
    Generic name: Fludarabine
    Manufactured by: Actavis
    Dosage: 50 mg
    Package: vial
    Prescribing information
    Report adverse events

    OXALIPLATINE

    OXALIPLATINE
    Generic name: Oxaliplatin
    Manufactured by: Actavis
    Dosage: 50, 100 mg
    Package: vial
    Prescribing information
    Report adverse events

    IRINOTECAN ACTAVIS

    IRINOTECAN ACTAVIS
    Generic name: Irinotecan
    Manufactured by: Actavis
    Dosage: 100 mg
    Package: vial
    Prescribing information
    Report adverse events

    GEMCITABINE ACTAVIS

    GEMCITABINE ACTAVIS
    Generic name: Gemcitabine
    Manufactured by: Actavis
    Dosage: 200 mg, 1 g
    Package: vial
    Prescribing information
    Report adverse events

    CUPRIPEN

    CUPRIPEN
    Generic name: D- Penicillamine
    Manufactured by: Rubio
    Dosage: 250 mg
    Package: 30 capsules
    Prescribing information
    Report adverse events

    RANOVER

    RANOVER
    Generic name: Ranitidine
    Manufactured by: Actoverco
    Dosage: 150 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    LETIZEN

    LETIZEN
    Generic name: Cetirizine
    Manufactured by: Actoverco under license Krka
    Dosage: 10 mg
    Package: 20 tablets
    Prescribing information
    Report adverse events

    ULTOP

    ULTOP
    Generic name: Omeprazol
    Manufactured by: Actoverco under license Krka
    Dosage: 20 mg
    Package: 28 capsules
    Prescribing information
    Report adverse events

    NOLPAZA

    NOLPAZA
    Generic name: Pantoprazole sodium
    Manufactured by: Actoverco under license Krka
    Dosage: 20, 40 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    METOVER

    METOVER
    Generic name: Metformin
    Manufactured by: Actoverco
    Dosage: 500 mg
    Package: 100 tablets
    Prescribing information
    Report adverse events

    ACTOFERON

    ACTOFERON
    Generic name: Interferon Beta-1b
    Manufactured by: Amegabiotech
    Dosage: 250 micrograms
    Package: 15 vials+ 15 prefilled syringes
    Prescribing information
    Report adverse events

    ACTOVEX

    ACTOVEX
    Generic name: Interferon Beta-1a
    Manufactured by: Amegabiotech
    Dosage: 30 micrograms
    Package: 4 vials + 4 prefilled syringes
    Prescribing information
    Report adverse events

    CIPRINOL

    CIPRINOL
    Generic name: Ciprofloxacin
    Manufactured by: Krka
    Dosage: 200 mg /100 ml
    Package: vial
    Prescribing information
    Report adverse events

    FROMILID

    FROMILID
    Generic name: Clarithromycin
    Manufactured by: Krka
    Dosage: 500 mg
    Package: 14 tablets
    Prescribing information
    Report adverse events

    SUPRIMUN

    SUPRIMUN
    Generic name: Mycophenolate Mofetil
    Manufactured by: Clausen
    Dosage: 500 mg
    Package: 50 tablets
    Prescribing information
    Report adverse events

    EQUIN VAGINAL CREAM

    EQUIN VAGINAL CREAM
    Generic name: Conjugated Esterogen
    Manufactured by: Ferrer
    Dosage: 0.625 mg
    Package: cream
    Prescribing information
    Report adverse events

    EQUIN

    EQUIN
    Generic name: Conjugated Estrogen
    Manufactured by: Ferrer
    Dosage: 0.625, 1,25 mg
    Package: 98 tablets
    Prescribing information
    Report adverse events

    DERMOFIX

    DERMOFIX
    Generic name: Sertaconazol
    Manufactured by: Ferrer
    Dosage: 20 g
    Package: cream
    Prescribing information
    Report adverse events

    CYCLOGEST

    CYCLOGEST
    Generic name: Bio-Identical Progesterone
    Manufactured by: Actavis
    Dosage: 200, 400 mg
    Package: 15 pessaries
    Prescribing information
    Report adverse events

    HYDRAPRES

    HYDRAPRES
    Generic name: Hydralazine
    Manufactured by: Rubio
    Dosage: 20 mg
    Package: 5 ampoules
    Prescribing information
    Report adverse events

    NOXPRIN

    NOXPRIN
    Generic name: Sodium Enoxaparin
    Manufactured by: Clausen
    Dosage: 20, 40, 60, 80 mg
    Package: 10 pre-filled syringes
    Prescribing information
    Report adverse events

    ACTOLOL

    ACTOLOL
    Generic name: Atenolol
    Manufactured by: Actoverco
    Dosage: 50, 100 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    GEMFACTO

    GEMFACTO
    Generic name: Gemfibrozil
    Manufactured by: Actoverco
    Dosage: 300 mg
    Package: 60 capsules
    Prescribing information
    Report adverse events

    ATOREXIN

    ATOREXIN
    Generic name: Atorvastatin
    Manufactured by: Actoverco
    Dosage: 10, 20, 40 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    LOSAVER

    LOSAVER
    Generic name: Losartan
    Manufactured by: Actoverco
    Dosage: 25, 50 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    LIPITOR

    LIPITOR
    Generic name: Atorvastatin
    Manufactured by: Pfizer
    Dosage: 10, 20 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    ZYLLT

    ZYLLT
    Generic name: Clopidogrel
    Manufactured by: Actoverco under license Krka
    Dosage: 75 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    CORYOL

    CORYOL
    Generic name: Carvedilol
    Manufactured by: Actoverco under license Krka
    Dosage: 25, 12.5, 6.25 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    AMLOBER

    AMLOBER
    Generic name: Amlodipine
    Manufactured by: Actoverco under license Krka
    Dosage: 5 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    VALSACOR

    VALSACOR
    Generic name: Valsartan
    Manufactured by: Actoverco under license Krka
    Dosage: 80, 160 mg
    Package: 28 tablets
    Prescribing information
    Report adverse events

    SUSTAC

    SUSTAC
    Generic name: Nitroglycerin extended release
    Manufactured by: Actoverco under license Krka
    Dosage: 6.4, 2.6 mg
    Package: 100 tablets
    Prescribing information
    Report adverse events

    RUBIFEN

    RUBIFEN
    Generic name: Methylphenidate
    Manufactured by: Rubio
    Dosage: 10 mg
    Package: 30 tablets
    Prescribing information
    Report adverse events

    LECTRUM

    LECTRUM
    Generic name: Leuprorelin Acetate
    Manufactured by: Eriochem-Argentine
    Dosage: 3.75 mg
    Package: Vial
    Prescribing information
    Report adverse events

    EMOZUL

    EMOZUL
    Generic name: Esomeprazole
    Manufactured by: Krka
    Dosage: 20,40
    Package: tablet
    Prescribing information
    Report adverse events

    AUTHORIZED DISTRIBIUTER

    Availability is a key concern in Actoverco. That is why we work with 4 authorized distribution companies in Iran. Maximizing coverage and access to our products is the goal of our experienced team of professionals.

    We have chosen 4 major distribution companies:

    1-Hejrat is the second largest distribution company covering pharmacies and the first covering hospitals

    2-Elite Darou is the Actover group owned distribution company, one of the first 100% private pharma distributors in Iran

    3-Razi is one of the leading distribution companies in the country

    4-Darou Pakh is one of the leading distribution companies in the country

    For distribution agreements outside Iran, please contact us to check product availability for your zone/countryexport@actoverco.com

    DRUG SAFETY

    Actoverco is focused on quality and product safety. We conduct accurate controls and evaluate all our suppliers and manufacturing processes.

    Actoverco is committed not only to all the applicable regulatory requirements but also to the highest international industry standards. It has successfully passed all GMP audits including GMP audit with PICS observers. 

     KRKA-Slovenia has also given GMP approval in the first QA audit in 2011.

     Merck Serono audited Actoverco factory in 2012 and approved it for production of its solid dosage form products starting with Glucophage 500 tablets.

     Actoverco has deployed IMS including: ISO 9001, ISO 14001 & OHSAS 18001 awarded by AGS (American Global Standards) in 2012 and renewed in 2014.

     Actoverco’s QC lab has also received accreditation certificate from MOH in 2014 and is regarded as one of a few accredited labs of pharmaceutical companies in Iran.

    We are also committed to the safe use of our product. We believe a safe drug prescription is also our responsibility. We provide comprehensive product knowledge and risk benefit information to the medical community and the patient.

    Pharmacovigilance

    Pharmacovigilance (PV) system is responsible for monitoring the safety of Actoverco products. Its main aim is to minimize the risks related to drugs used and to maximize their benefits. The vision of the Actoverco Pharmacovigilance Department is to improve nationwide patient safety and wellbeing by reducing the risk of medicines used by patients and the general public.

    Drug Information Center 

    Drug Information Center of Actover Pharmaceutical Company is stablished in October 2015 as a division of the Pharmacovigilance department. The main purposes of DIC encompass rational prescription and use of drugs, increase of awareness, easy access to the authentically most up-to-date, precise, and pertinent information about our company’s drug products as well as to safeguard the health, financial and legal interests of the patients.

    If you or your patient experience any unanticipated side effect or have a complaint about a product please report adverse events. 


    HEALTH RELATED WEBSITES

    In Actoverco, we not only focus on producing and distributing medicines, indeed we believe in making health information. Therefore we have created specific magazine & websites.  



    Salamsalamat Magazine

    This is a magazine which is published and distributed every month throughout the drugstores, hospitals, clinics and offices of Tehran & some cities in Iran. Each magazine contains recent reliable articles about health & lifestyle. The aim of this distribution is improving general knowledge of people. To verify accessing this magazine in the internet, we have loaded the electronic version in the following address: www.salamsalamt.com  


    msmarkaz.com

    It is a website dedicated for multiple sclerosis patients, where they can find information about the disease and treatments as well as stories about other patients, news, group gatherings and a forum where they can share their experiences.


    myxenover.com

    To boost the effect of Xenover (Orlistat), we have created a microsite to pair this treatment with healthy routines. This website contains material from recipes to physical activities and tips to change lifestyle habits. 



  • ACTING ETHICALLY

    we understand that the pharmaceutical sector is not comparable to any other industryEthical behavior is integrated in the core of our business, placing the well being of the patient as our top priorityThis is why we are profoundly committed to our responsibility in every aspect of our business:

    • Ethics in research
    • In all our research, including our clinical studies, we respect the patient and his rights as well as the health care providers.

    • Ethics in production
      Producing high quality and safe drugs is not only a marketing strategy, for us it is our responsibility to provide trustworthy pharmaceuticals.

    • Ethics in promotional activities
      We believe complete and accurate information is a right for healthcare professionals and patients, in order to make the most informed prescription decision.  We work hard to promote our products with factual information, in a way to avoid misleading our audiences.

    For more information consult our code of ethical practices.
    CODE-OF-ETHICS.pdf

    SOCIAL RESPONSIBILITY

    We believe it is our responsibility to leave the world a better place for next generations. That is why we go beyond our legal obligations, increasing the welfare of the most vulnerable individuals of our society.  

    We work in three different fronts:

     

    Education is the key to building a future. As part of the Dr. Mostafa Naraghi Foundation, we build schools in underprivileged areas. But a building is not enough to ensure education. That is why we contribute with learning and scholarship programs and psychological support.

    Access to medicine and surgery is every person’s right. We collaborate with different foundations by donating MS and Cancer drugs as well as paying for heart and reconstructive surgery for children.

    Food program is a real problem in some of the areas where we work. Some families are unable to offer even one meal a day to their children. We contribute with two initiatives in this direction: The “One meal per day” program that feeds over 1.000 children per day and regular food packages to 300 families so that they can prepare hot food in their homes.

     

    All the Corporate Social Responsibility activities of Actoverco are coordinated by the Dr. Mostafa Naraghi Foundation.

    >>go to website

    PARTNERS

    The Corporate Social Responsibility activities of Actoverco are coordinated by the Dr. Mostafa Naraghi Foundation. Working with an independent executive team and under the control of the supervisory board.

    WE ALSO COLLABORATE WITH:

    Kahrizak
    is a private charitable organization with over 1600 beds where physically handicapped or elderly individuals with no financial resources can live.

    Chain of Hope
    is a French NGO operating in over 30 countries including in Iran. We collaborate by taking in charge surgery costs for young children.

  • PRESS RELEASE

    Press releases: In this section you can find our latest press releases If you need more detailed information about Actoverco please read our press kit or contact us at:
    press@actoverco.com
    The first Symposium on Heart & Brain

    10/10/2016
    The first Symposium on Heart & Brain
    The first symposium on Heart & Brain in Iran was held by Actoverco.

    German economic delegation visited the Actoverco pharmaceutical factory

    10/9/2016
    German economic delegation visited the A...
    Tarek Al-Wazir, Hessian Minister of Economics, Energy, Transport and Regional D...

    18TH International Congress on Cardiovascular Updates

    10/10/2016
    18TH International Congress on Cardiovas...
    Between 13th to 16th September, there was an international congress on cardiovas...

    15th Annual Conference of Iranian Association Pharmacy

    10/10/2016
    15th Annual Conference of Iranian Associ...
    The annual conference of Iranian association pharmacy, was held on 24th to 26t...

    The Second Congress of Nephrology and Urology of Iran

    10/10/2016
    The Second Congress of Nephrology and Ur...
    The Second Congress of Nephrology and Urology of Iran was held on second to 5th ...

    HAPPY DR'S DAY

    10/10/2016
    HAPPY DR'S DAY
    It's Dr's day & we want to describe you a day full of smile

    Official starting partnership with Merck

    10/16/2014
    Official starting partnership with Merck
    with effort of Actoverco Company and Tehran university cooperation, with partici...

    TV program

    6/14/2014
    TV program
    Actoverco pharmaceutical specialists took part in a live TV show

    CLINICAL TRIAL

    Clinical Safety and Efficacy of Suprimun®

    4/26/2015
    Clinical Safety and Efficacy of Suprimun...
    ). In Suprimun and Cellcept groups, 93.1% and 94.4% of patients were alive witho...

  • JOIN ACTOVERCO

    Join one of the leading pharmaceutical companies in Iran. Our expanding strategies are creating exiting career opportunities across the group.

    SALES & MARKETING
    PRODUCTION
    COMMERCIAL AFFAIRS
    MEDICAL AFFAIRS
    ADMINISTRATION AND ACCOUNTING

    Please send your CV to info@actoverco.com, indicating the position you are applying for in the subject of your

    WHY WORK FOR ACTOVERCO

    We know that in an ever-changing business environment, human capital has become the main source of competitive advantage.

    Working for Actoverco you will have the opportunity to develop your skills and progress your career across abroad range of business areas and functions. You will have the necessary support from managers and colleagues to achieve your professional goals.

    Our training programs and your learning experiences will help you progress in your field and enhance your expertise.

    See how your dedication and hard work is rewarded in Actoverco, offering you better opportunities in a fast-growing company.

    >>Search for job openings

    EMPLOYMENT PROCESS

    1. Review employee application
    2. Selection of candidates and interview with HR
    3. Testing (including psychological testing,  depending on department requirements)
    4. Second round of interviews with shortlisted candidates
    5. Further interviews if necessary
    6. Final selection and emplyoments
  • Reporter Information:
    General Physician: Nurse: Pharmacist: Other :
    1. Patient Details:
    2. Suspected reaction(s):
    3. Date reaction(s) started:
    4. Duration of the reaction(s):
    5. Patient history of any reaction including allergies:
    6. Patient medical history:
    7. Did the reaction(s) improve when the drug was discontinued?
    8. Did the reaction(s) reappear when the drug was readministered?
    9. Outcome:
    10. Did the reaction(s) lead to hospitalization?
    11. Paraclinic findings related to the reaction(s):
    12. Suspected medicine(s):
    Medicine Dosage form & potency* Daily dosage Route Indication Date started Date discontinued Manufacturer Batch No.
    13. Medications taken at the time of ADR:
    Medicine Dosage form & potency* Daily dosage Route Indication Date started Date discontinued Manufacturer Batch No.
    Additional relevant information:
    * The “potency” refers to the amount of active ingredient in the pharmaceutical dosage form (e.g. 100 mg Tablet …)